Form 4 Tracker
LENZ Therapeutics, Inc.
LENZ

10 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 27, 2026Mar 30 12:47 PMJeffrey P. GeorgeDirector
Purchase
5,592$8.92$49.9K5,592(D)

View →

Mar 27, 2026Mar 30 12:46 PMEvert B. SchimmelpenninkDirector, President, CEO and Secretary
Purchase
28,089$8.95$251.4K77,289(D)

View →

Mar 27, 2026Mar 30 12:46 PMDaniel R. ChevallardChief Financial Officer
Purchase
7,500$8.57$64.3K12,886(D)

View →

Nov 17, 2025Nov 17 9:38 PMSHAWN OLSSON
Proposed Sale
40,000$25.60$1.0M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 15, 2026Jun 16 12:22 AMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Grant/Award
22,100$6.6322,100(I)

View →

Jun 15, 2026Jun 16 12:18 AMJeffrey P. GeorgeDirector
Grant/Award
22,100$6.6322,100(D)

View →

Jun 15, 2026Jun 16 12:18 AMKimberlee C DrapkinDirector
Grant/Award
22,100$6.6322,100(D)

View →

Jun 15, 2026Jun 16 12:18 AMJames W MccollumDirector
Grant/Award
22,100$6.6322,100(D)

View →

Jun 15, 2026Jun 16 12:18 AMShelley B ThunenDirector
Grant/Award
22,100$6.6322,100(D)

View →

Jun 15, 2026Jun 16 12:18 AMFrederic GuerardDirector
Grant/Award
22,100$6.6322,100(D)

View →

Jun 15, 2026Jun 16 12:17 AMZachary ScheinerDirector
Grant/Award
22,100$6.6322,100(D)

View →